Colorectal cancer (CRC) is the fourth most commonly diagnosed malignancy in adults. Although significant progress has been made in early detection, diagnosis and treatment, CRC remains the second leading cause of cancer-related deaths in the U.S. and first after smoking-related deaths are excluded. One factor contributing to successful outcome from CRC is early detection, largely performed by periodic colonoscopy. Recently, there is growing appreciation that cancer morphology at the time of presentation can greatly impact the frequencies of detection. In particular, classical polypoid lesions (polyps) are detected and removed during colonoscopy at a much higher frequency than flat ployps, although there is growing evidence that the latter may have a higher propensity to become invasive at much smaller sizes. Little is known about how or why certain cancer pathologies form or even whether this is a stochastic process or if there are specific genetic or environmental factors contributing to distinct cancer morphologies. Fortuitously, we have discovered novel mouse models of human CRC that consistently and almost exclusively produce flat adenomas compared to the much more frequent polypoid adenoma that occurs in the vast majority of mouse models. These results strongly suggest that there are specific genetic factors that determine CRC morphology. Using these new mouse models, we propose to identify the molecular characteristics that distinguish polypoid from flat CRCs and to identify the genetic factors responsible for determining cancer morphology. Although we will largely rely on a discovery-driven genetic approach to achieve these goals, our underlying hypotheses are that a distinct set of cancer modifiers controls susceptibility to flat CRCs and that there there exists specific host genetic factors that determine the type of CRC morphology an individual will develop. Investigation of this hypothesis will be achieved by 1) molecularly characterizing factors contributing to distinct histopathologies, 2) determining the number and genetic locations of flat adenoma modifiers, and 3) fine mapping and identifying candidate modifiers genes.

Public Health Relevance

The identification genetic factors that are responsible for specific subsets of colorectal cancers offers hope that personalized medicine can be applied to the treatment of colorectal cancer. The proposed studies are aimed at identifying genetic differences among individuals that predispose them to develop flat adenomas, a histologically distinct type of colorectal cancer that is difficult to detect during routine colonoscopy. The identification of genetic polymorphisms predisposing patient to flat adenomas will be useful as prognostic markers for individuals needing extra scrutiny during colonoscopy.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Cancer Genetics Study Section (CG)
Program Officer
Johnson, Ronald L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
North Carolina State University Raleigh
Schools of Earth Sciences/Natur
United States
Zip Code
Didion, John P; Morgan, Andrew P; Clayshulte, Amelia M-F et al. (2015) A multi-megabase copy number gain causes maternal transmission ratio distortion on mouse chromosome 2. PLoS Genet 11:e1004850
Bautz, David J; Broman, Karl W; Threadgill, David W (2013) Identification of a novel polymorphism in X-linked sterol-4-alpha-carboxylate 3-dehydrogenase (Nsdhl) associated with reduced high-density lipoprotein cholesterol levels in I/LnJ mice. G3 (Bethesda) 3:1819-25
Eversley, Chevonne D; Yuying, Xie; Pearsall, R Scott et al. (2012) Mapping six new susceptibility to colon cancer (Scc) loci using a mouse interspecific backcross. G3 (Bethesda) 2:1577-84
Eversley, Chevonne D; Clark, Tavia; Xie, Yuying et al. (2010) Genetic mapping and developmental timing of transmission ratio distortion in a mouse interspecific backcross. BMC Genet 11:98
Pysz, Marybeth A; Leontieva, Olga V; Bateman, Nicholas W et al. (2009) PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1. Exp Cell Res 315:1415-28
Uronis, Joshua M; Threadgill, David W (2009) Murine models of colorectal cancer. Mamm Genome 20:261-8
Fiske, William H; Threadgill, David; Coffey, Robert J (2009) ERBBs in the gastrointestinal tract: recent progress and new perspectives. Exp Cell Res 315:583-601
Radiloff, Daniel R; Rinella, Erica S; Threadgill, David W (2008) Modeling cancer patient populations in mice: complex genetic and environmental factors. Drug Discov Today Dis Models 4:83-88
Kaiser, Sergio; Park, Young-Kyu; Franklin, Jeffrey L et al. (2007) Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol 8:R131
Uronis, Joshua M; Herfarth, Hans H; Rubinas, Tara C et al. (2007) Flat colorectal cancers are genetically determined and progress to invasion without going through a polypoid stage. Cancer Res 67:11594-600

Showing the most recent 10 out of 17 publications